The recent study by Karimjee et al. (2025) focuses on the DE50-MD dog model of Duchenne muscular dystrophy (DMD). This model is crucial for testing new treatments for DMD, as it closely mimics the human condition. Animal models like this are essential for evaluating potential therapies because they can replicate the disease's progression and symptoms.
The use of such models is important for developing effective treatments for DMD, which is a fatal genetic disorder. By studying these models, researchers can better understand how the disease progresses over time and how different interventions might slow or halt this progression. This research could lead to more effective therapies for managing DMD symptoms and improving the quality of life for those affected.
Clinical Trials
This is a list of upcoming or ongoing clinical trials that are actively recruiting and have been listed or updated in the last two weeks: